Ciao Allalba traduttore polo like kinase 1 Lada Decano consulente
Inhibition of polo-like kinase 1 (PLK1) facilitates reactivation of gamma-herpesviruses and their elimination | PLOS Pathogens
A unified view of spatio-temporal control of mitotic entry: Polo kinase as the key | Open Biology
PLK-1 Inhibitors: New Treatment for MDS? - ppt download
Polo-like kinases: structural variations lead to multiple functions | Nature Reviews Molecular Cell Biology
Polo-like Kinase 1 Inhibitors in Human Cancer Therapy: Development and Therapeutic Potential | Journal of Medicinal Chemistry
Development of a Polo-like Kinase-1 Polo-Box Domain Inhibitor as a Tumor Growth Suppressor in Mice Models | Journal of Medicinal Chemistry
Polo-like kinases: structural variations lead to multiple functions | Nature Reviews Molecular Cell Biology
Switching Polo-like kinase-1 on and off in time and space: Trends in Biochemical Sciences
Role of polo-like kinase 1 (PLK1) overexpression in cancer. In addition... | Download Scientific Diagram
Functional Dynamics of Polo-Like Kinase 1 at the Centrosome | Molecular and Cellular Biology
Structural basis for the inhibition of Polo-like kinase 1 | Nature Structural & Molecular Biology
The Polo-like kinase 1 inhibitor onvansertib represents a relevant treatment for head and neck squamous cell carcinoma resistant to cisplatin and radiotherapy [Abstract]
PDF] The role of polo-like kinase 1 in carcinogenesis: cause or consequence? | Semantic Scholar
Polo-like kinase 1 (PLK1) signaling in cancer and beyond - ScienceDirect
Continuous polo-like kinase 1 activity regulates diffusion to maintain centrosome self-organization during mitosis | PNAS
Figure 2 from Polo-like kinase (PLK) inhibitors in preclinical and early clinical development in oncology. | Semantic Scholar
Polo-like kinase 1 (PLK1) signaling in cancer and beyond - ScienceDirect
Frontiers | PLK-1 Regulation of Asymmetric Cell Division in the Early C. elegans Embryo
Frontiers | A Perspective on Polo-Like Kinase-1 Inhibition for the Treatment of Rhabdomyosarcomas
Pharmaceuticals | Free Full-Text | Inhibition of Polo-like Kinase 1 by HMN-214 Blocks Cell Cycle Progression and Inhibits Neuroblastoma Growth